Abstract
Introduction: Establishment of a cell classification platform for evaluation and selection of human pluripotent stem cells (hPSCs) is of great importance to assure the efficacy and safety of cell-based therapy. In our previous work, we introduced a discriminant function that evaluates pluripotency from the cells’ glycome. However, it is not yet suitable for general use. Methods: The current study aims to establish a high-precision cell classification platform introducing supervised machine learning and test the platform on glycome analysis as a proof-of-concept study. We employed linear classification and neural network to the lectin microarray data from 1577 human cells and categorized them into five classes including hPSCs. Results: The linear-classification-based model and the neural-network-based model successfully predicted the sample type with accuracies of 89% and 97%, respectively. Conclusions: Because of the high recognition accuracies and the small amount of computing resources required for these analyses, our platform can be a high precision conventional cell classification system for hPSCs.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 195-201 |
| Number of pages | 7 |
| Journal | Regenerative Therapy |
| Volume | 15 |
| DOIs | |
| State | Published - Dec 2020 |
| Externally published | Yes |
Keywords
- Artificial intelligence
- Lectin microarray
- Linear classification
- Neural network
- Pluripotent stem cells
ASJC Scopus subject areas
- Biomaterials
- Biomedical Engineering
- Developmental Biology
Fingerprint
Dive into the research topics of 'High-precision multiclass cell classification by supervised machine learning on lectin microarray data'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS